Screener
aTyr Pharma ATYR Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses | 6,690 | 9,791 |
| Current portion of operating lease liability | 946 | 836 |
| Current portion of financing lease liability | 518 | 630 |
| Total current liabilities | 11,396 | 15,148 |
| Long-term operating lease liability, net of current portion | 9,799 | 10,308 |
| Long-term financing lease liability, net of current portion | 36 | 259 |
| Commitments and contingencies (Note 4) | ||
| Stockholders’ equity: |
Item 1. Financial Statements
FAQ
- What is aTyr Pharma's total current liabilities?
- aTyr Pharma (ATYR) reported total current liabilities of $11.4M in Q2 2026.
- How has aTyr Pharma's total current liabilities changed year-over-year?
- aTyr Pharma's total current liabilities decreased by 26.6% year-over-year, from $15.53M to $11.4M.
- What is the long-term trend for aTyr Pharma's total current liabilities?
- Over 5 years (2020 to 2025), aTyr Pharma's total current liabilities has grown at a 20.9% compound annual growth rate (CAGR), from $5.86M to $15.15M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about aTyr Pharma's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude